glp 1 receptor agonists beyond their pancreatic effects The Multifaceted Nature of GLP-1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases GLP-1 Receptor Agonists as Treatments
Description
10.1126/scitranslmed.aan0972
Most evidence to date reflects changes in downstream or adaptive pathways, such as inflammation, mitochondrial function, and metabolic regulation, rather than direct modification of the primary sources of molecular damage
HARMONY 7 study group
Survodutide may directly reduce both
We adjust the titration schedule rather than push through
& Halpern, B
